Evidence map›Paper›PMID 27518576›Full record

ReviewWorld journal of urology2017

Prostate cancer progression and mortality: a review of diet and lifestyle factors.

Sam F Peisch, Erin L Van Blarigan, June M Chan, Meir J Stampfer, Stacey A Kenfield

Open access · greenAbstract readReview
In one paragraph

Review in World journal of urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 5 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 5 syntheses or guidelines pooled it, 189 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Couple-based lifestyle intervention for minority prostate cancer survivors: a randomized feasibility trial.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Prostate Cancer Mortality Trend in Montenegro 1990-2018.Iranian journal of public health · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sam F PeischChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Erin L Van BlariganDepartment of Urology, University of California-San Francisco, San Francisco, CA, USA.
June M ChanDepartment of Urology, University of California-San Francisco, San Francisco, CA, USA.
Meir J StampferChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Stacey A KenfieldDepartment of Urology, University of California-San Francisco, San Francisco, CA, USA. stacey.kenfield@ucsf.edu.
University of California, San Francisco · USBrigham and Women's Hospital · USHarvard University · US

Funding

Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
Impact of Web-Based Lifestyle Interventions on Prostate Cancer PrognosisR01CA207749 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KENFIELD, STACEY · 2016 to 2021
$3.3M
Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer PrognosisR01CA181802 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAN, JUNE ML · 2014 to 2019
$3.1M
Prostate Microenvironmental & Prostate Cancer ProgressionR01CA106947 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAN, JUNE ML · 2006 to 2009
$1.5M
Diet After Colorectal Cancer : Observational Studies to Behavioral InterventionsK07CA197077 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAN BLARIGAN, ERIN LYNN · 2016 to 2020
$885k
A Randomized Clinical Trial of Exercise for Men with Metastatic Prostate CancerR21CA184605 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KENFIELD, STACEY · 2015 to 2016
$379k
NCI NIH HHS K07 CA197077NCI NIH HHS R01 CA106947NCI NIH HHS R01 CA181802NCI NIH HHS R01 CA207749NCI NIH HHS R21 CA184605NCI NIH HHS UM1 CA167552
6 · The paper itself

Abstract

purposeTo review and summarize evidence on the role of diet and lifestyle factors and prostate cancer progression, with a specific focus on habits after diagnosis and the risk of subsequent disease recurrence, progression, or death.

methodsGiven the well-documented heterogeneity of prostate cancer and the long survivorship of the majority of diagnoses, our goal was to summarize and describe modifiable risk factors for clinically relevant prostate cancer. We focused where possible on epidemiologic studies of post-diagnostic habits and prostate cancer progression, defined as recurrence (e.g., PSA risk, secondary treatment), metastasis, or death. Where data were limited, we also describe evidence on risk factors and indicators of prostate cancer aggressiveness at diagnosis.

resultsA variety of dietary and lifestyle factors appear to affect prostate cancer progression. Several generally widely recommended lifestyle factors such as not smoking, maintaining a healthy body weight, and regular vigorous physical exercise also appear to affect prostate cancer progression. Several dietary factors, such as tomato sauce/lycopene, cruciferous vegetables, healthy sources of vegetable fats, and coffee, may also have a role in reducing risk of prostate cancer progression.

conclusionDiet and lifestyle factors, in particular exercise and smoking cessation, may reduce the risk of prostate cancer progression and death. These promising findings warrant further investigation, as their overall impact might be large.

Indexed as

Diet, HealthyDisease ProgressionLife StyleAdultAgedAttitude to HealthExerciseHumansIncidenceMaleMiddle AgedOverweightProstatic NeoplasmsRisk AssessmentRisk FactorsSmokingDietLethal prostate cancerLifestyleProstate cancer progression

Identifiers

PMID27518576
PMCPMC5472048
OpenAlexW2517427649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.